{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "binds",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:Q16473",
      "entity_text" : "Xa",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:9875401",
      "entity_text" : "rivaroxaban",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : true,
    "context" : {
      "Species" : [ "taxonomy:9606" ]
    }
  },
  "verbose_text" : "XREF_BIBR XREF_BIBR XREF_BIBR XREF_BIBR XREF_BIBR XREF_BIBR XREF_BIBR A recent study by Jourdi et al reported that rivaroxaban binds free factor Xa with a 4-fold higher on-rate than apixaban and a 1.5-fold lower K d, and modeling data suggested that this phenomenon explains the greater effect of rivaroxaban on the PT.",
  "reading_complete" : "2020-08-02T12:32:57Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T12:30:02Z",
  "trigger" : "binds",
  "evidence" : [ "rivaroxaban binds free factor Xa" ],
  "pmc_id" : "6524873",
  "score" : 0
}